Diabetes Drugs Go Head-to-Head in Study (HealthDay)

HealthDay – THURSDAY, Dec. 3 (HealthDay News) — A class of drugs still taken by
millions of people with type 2 diabetes is associated with a higher risk
of dying and heart failure than the newer treatment metformin, researchers
say.

Related posts:

1. Kaiser Permanente Study First To Measure Gestational Diabetes Risk Among 14 Ethnic Groups In Hawaii
2. UNC Scientists Coordinate Study To Determine Link Between Insulin Use And Cancer In People With Diabetes